Download PDF
Aktuelle Kardiologie 2017; 6(03): 213-219
DOI: 10.1055/s-0043-110674
Übersichtsarbeit
Georg Thieme Verlag KG Stuttgart · New York

Der tragbare Defibrillator (WCD) – EHRA-Review

The Wearable Cardioverter-Defibrillator (WCD) – EHRA-Review
Christian Perings
Medizinische Klinik l – Kardiologie, Pneumologie, Elektrophysiologie, Intensivmedizin, Katholisches Klinikum Lünen/Werne – St.-Marien-Hospital GmbH, Lünen
› Author Affiliations
Further Information

Publication History

Publication Date:
20 June 2017 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der Kardioverter-Defibrillator nimmt eine zentrale Rolle in der Prävention des plötzlichen Herztodes ein. Neben identifizierbaren Patientengruppen mit anhaltend erhöhtem Risiko für ein arrhythmogenes Ereignis lassen sich auch diejenigen mit einem nur passager erhöhten Risiko für vital bedrohliche Tachyarrhythmien identifizieren. Hier findet der tragbare Kardioverter-Defibrillator (WCD) seine Anwendung. Neben der Funktionsweise des Systems werden die aktuellen Anwendungsbereiche inklusive der Leitlinienempfehlungen zusammengefasst.

Abstract

The cardioverter-defibrillator plays a crucial role in the prevention of sudden cardiac death (SCD). Apart from patients suffering from persistent SCD risk there are those with an only temporary one. This is where the wearable cardioverter-defibrillator applies. Besides a technology overview current indications and guidelines will be outlined.

Schlüsselwörter

plötzlicher Herztod - tragbarer Cardioverter-Defibrillator - WCD - Primärprävention

Key words

sudden cardiac death - wearable cardioverter defibrillator - WCD - primary prevention
 

  • Literatur

  • 1 Epstein AE, DiMarco JP, Ellenbogen KA. et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-e62
    CrossrefPubMedGoogle Scholar
  • 2 Priori SG, Blomstrom-Lundqvist C, Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17: 1601-1687
    PubMedGoogle Scholar
  • 3 Reek S, Burri H, Roberts PR. et al. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace 2016; 19: 335-345
    PubMedGoogle Scholar
  • 4 Al-Khatib SM, Hellkamp A, Curtis J. et al. Non-evidence-based ICD implantations in the United States. JAMA 2011; 305: 43-49
    CrossrefPubMedGoogle Scholar
  • 5 Hohnloser SH, Kuck KH, Dorian P. et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-2488
    CrossrefPubMedGoogle Scholar
  • 6 Steinbeck G, Andresen D, Seidl K. et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009; 361: 1427-1436
    CrossrefPubMedGoogle Scholar
  • 7 Exner DV, Kavanagh KM, Slawnych MP. et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007; 50: 2275-2284
    CrossrefPubMedGoogle Scholar
  • 8 Solomon SD. Zelenkofske S, McMurray JJ et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-2588
    CrossrefPubMedGoogle Scholar
  • 9 VEST Study. Im Internet: https://clinicaltrialsgov/ct2/show/NCT01446965 Stand: 01.09.2015
    PubMedGoogle Scholar
  • 10 Zishiri ET, Williams S, Cronin EM. et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2013; 6: 117-128
    CrossrefPubMedGoogle Scholar
  • 11 Kao AC, Krause SW, Handa R. et al. Wearable defibrillator use In heart Failure (WIF) Investigators. Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord 2012; 12: 123
    CrossrefPubMedGoogle Scholar
  • 12 Feldman AM, Klein H, Tchou P. et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004; 27: 4-9
    CrossrefPubMedGoogle Scholar
  • 13 Klein HU, Meltendorf U, Reek S. et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol 2010; 33: 353-367
    CrossrefPubMedGoogle Scholar
  • 14 Chung MK, Szymkiewicz SJ, Shao M. et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 2010; 56: 194-203
    CrossrefPubMedGoogle Scholar
  • 15 Kutyifa V, Moss AJ, Klein H. et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015; 132: 1613-1619
    CrossrefPubMedGoogle Scholar
  • 16 Singh M, Wang NC, Jain S. et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol 2015; 66: 2607-2613
    CrossrefPubMedGoogle Scholar
  • 17 Kindermann I, Kindermann M, Kandolf R. et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639-648
    CrossrefPubMedGoogle Scholar
  • 18 Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J 2012; 164: 215-221
    CrossrefPubMedGoogle Scholar
  • 19 Madias C, Fitzgibbons TP, Alsheikh-Ali AA. et al. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes. Heart Rhythm 2011; 8: 555-561
    CrossrefPubMedGoogle Scholar
  • 20 Sharkey SW, Windenburg DC, Lesser JR. et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010; 55: 333-341
    CrossrefPubMedGoogle Scholar
  • 21 Nascimento FO, Krishna RK, Hrachian H. et al. Wearable cardioverter defibrillator in stress cardiomyopathy and cardiac arrest. BMJ Case Rep 2013; DOI: 10.1136/bcr-2013-009789.
    CrossrefPubMedGoogle Scholar
  • 22 Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011; 58: 659-670
    CrossrefPubMedGoogle Scholar
  • 23 Duncker D, Haghikia A, Konig T. et al. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail 2014; 16: 1331-1336
    CrossrefPubMedGoogle Scholar
  • 24 Hilfiker-Kleiner D, Haghikia A, Nonhoff J. et al. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015; 36: 1090-1097
    CrossrefPubMedGoogle Scholar
  • 25 Gronda E, Bourge RC, Costanzo MR. et al. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant 2006; 25: 1043-1056
    CrossrefPubMedGoogle Scholar
  • 26 Opreanu M, Wan C, Singh V. et al. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: a national database analysis. J Heart Lung Transplant 2015; 34: 1305-1309
    CrossrefPubMedGoogle Scholar
  • 27 Foley RN, Gilbertson DT, Murray T. et al. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011; 365: 1099-1107
    CrossrefPubMedGoogle Scholar
  • 28 Wan C, Herzog CA, Zareba W. et al. Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 2014; 19: 247-257
    CrossrefPubMedGoogle Scholar
  • 29 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200
    CrossrefPubMedGoogle Scholar